One intelligence layer to accelerate your competitive advantage.
Purpose-built for Life Sciences commercial leaders. Not a dashboard. The operating layer between the signal and the decision.
Interface layer
Ask Marlow
Your AI analyst, fully briefed on every signal below
▲
Analysis layer
Benchmarks
Peer financial context
Op margin · R&D% · Revenue growth
Analysis layer
GTM Diagnostic
Structured GTM assessment
Market position · ICP coverage · Recommendations
▲
Core layer
Customer Intelligence
950+ accounts
mIQ scoring · trial activity · profiles
Core layer
Competitor Intelligence
105+ baselines
mGS scoring · posture · recent moves
Core layer
Top Opportunities
Signal-triggered
Immediate · This Quarter · Watch plays
▲
Foundation · always running
Intelligence Brief
Signal ingestion · synthesis · delivery · Tue + Fri
105+
competitors
950+
accounts
16000+
trials
LIVE
01
Intelligence Brief
FREETwice-weekly signal synthesis — filtered to what a commercial leader actually needs to act on.
- →Tuesday and Friday briefs delivered by email — curated from earnings calls, trial registrations, and macro demand signals
- →Each item: Headline → Why it matters → What to watch → Source
- →Full coverage across all 105+ monitored competitors and 950+ accounts
Brief surfaces a signal? Top Opportunities turns it into a play.
02
Top Opportunities
INSIGHTSSignal-triggered GTM plays ranked by urgency — so you always know what to act on this week, this quarter, and what to watch.
- →Plays organized by urgency bucket: Weekly, Monthly, Quarterly, and Watch — driven by account press releases, pipeline events, and asset signals
- →Each opportunity surfaces the triggering signal, the account context, and the recommended commercial action
- →Updated continuously as new signals land — your GTM priority list reflects what happened this week, not last quarter's planning doc
RTW Plays · This Week
Weekly
Eli Lilly
Phase 3 enrollment opened
Monthly
AstraZeneca
dato-DXd ADC expansion
BioNTech
BNT122 Phase 2 readout
Quarterly
Novartis
PLUVICTO capacity signal
Want account context? Accounts has the full profile.
03
Accounts
INSIGHTSDeep profiles on 950 life sciences accounts — mIQ buying propensity score, clinical trial activity, pipeline signals, and financials in one view.
- →mIQ Score (0–10) for every account, recalculated weekly from CT.gov trial activity, pipeline stage, and financial posture — know who is ready to buy before your reps do
- →16000+ active clinical trials tracked across the account set — phase transitions and breakthrough designations surface automatically in the account score
- →Full account profile: FDA actions, capacity events, leadership changes, and financial indicators updated from public filings
Eli Lilly LLY
GLP-1Biologics
9.4
TOP-TIER · ↑ +0.3
mIQ Score
Score breakdown
Financial Capacity22/25
R&D Commitment18/20
Pipeline Urgency21/25
Commercial Readiness17/20
Signal Velocity9/10
34 active trials · last signal: eloralintide Phase 3 recruiting opened
Need the competitive frame? Competitor Intelligence shows who else is moving.
04
Competitor Intelligence
INSIGHTS108 competitor baselines with strategic posture, recent moves, and mGS Score — updated every week.
- →mGS (Marlow Growth Score): composite of real growth, commercial efficiency, and trajectory — 8-quarter trend lets you see who is gaining structural momentum vs. buying time
- →Competitor baseline: strategic narrative, product moves, pricing signals, capacity events, recent press — everything needed to frame a board discussion
- →Earnings watch: key quotes and guidance changes surfaced immediately after each call — no waiting for analyst summaries
Thermo Fisher TMO
Life Sciences Tools · Pharma Services
45
↑ +1 QoQ
mGS Score
8-quarter mGS trend
45
Q2'24Q3'24Q4'24Q1'25Q2'25Q3'25Q4'25Q1'26
⚡ Latest: Q1 2026 organic growth +2%; bioproduction recovery underway; pharma services stable
Peer financial context? Benchmarks shows where each competitor sits structurally.
05
Benchmarks
PROPeer financial comparison across the monitored set — margin, R&D efficiency, and revenue growth in a single terminal view.
- →8-quarter trend data across operating margin, revenue per employee, SG&A efficiency, and R&D intensity — sort by any metric
- →See who is structurally winning vs. buying growth — the context your board expects you to have before the QBR
- →Identifies leading structural risk flags: margin compression, R&D underinvestment, and SG&A creep before they show up in share price
Need to go deeper on a specific competitor? Ask Marlow ties it all together.
06
Ask Marlow
PROYour Life Sciences intelligence analyst — on call, fully briefed, and already up to speed on your entire account and competitor universe.
- →AI analyst with your full platform context loaded: mIQ scores, mGS scores, trial data, competitor baselines, macro signals — answers are sourced, not hallucinated
- →Ask anything: which accounts are most likely to expand capacity, where a competitor is gaining share, how to frame your position for the board
- →Upload your own docs — call notes, positioning decks, field intel — and Marlow synthesizes internal and external context in the same answer
m
Ask Marlow
● Live context: 950 accounts · 108 competitors · 16000+ trials
Ask anything about your market...
↑
Ready for a full GTM assessment? GTM Diagnostic structures it end-to-end.
07
GTM Diagnostic
PROStructured AI-powered diagnosis of any company's market position, ICP coverage, and GTM effectiveness — with prioritized tactical recommendations.
- →Three-panel assessment across market position, ICP coverage, and GTM effectiveness — each with risk level, evidence-backed findings, and confidence-weighted hypotheses
- →Generates across 9 recommendation categories: Account Targeting, Marketing, Sales & BD, Routes to Market, GTM Investment, Service Model, AI GTM Enablers, Enablement, and Sales Compensation
- →Submit field intel — meeting notes, competitive observations, rep feedback — and Marlow incorporates it into the next refresh. Drill into any finding directly with Ask Marlow
Live and updating
105+
competitors monitored
950+
customer accounts scored
16000+
active clinical trials tracked
Updated continuously. Synthesized weekly. Available now.